| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.1935 |
| P698 | PubMed publication ID | 16450333 |
| P50 | author | Helmut Friess | Q15453363 |
| Jorg Kleeff | Q57039562 | ||
| P2093 | author name string | Bergmann F | |
| Esposito I | |||
| Riedl S | |||
| Penzel R | |||
| Schirmacher P | |||
| Giese N | |||
| Barcena U | |||
| Chaib-Harrireche M | |||
| Kayed H | |||
| P2860 | cites work | TGFbeta1, back to the future: revisiting its role as a transforming growth factor | Q35701011 |
| Involvement of large tenascin-C splice variants in breast cancer progression | Q35791432 | ||
| Expression and degeneration of tenascin-C in human lung cancers | Q36294957 | ||
| Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. | Q37381233 | ||
| P433 | issue | 5 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 673-685 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Tenascin C and annexin II expression in the process of pancreatic carcinogenesis | |
| P478 | volume | 208 |
| Q30431185 | A functional proteomic method for biomarker discovery |
| Q36792047 | A migration signature and plasma biomarker panel for pancreatic adenocarcinoma |
| Q33343004 | A mouse to human search for plasma proteome changes associated with pancreatic tumor development |
| Q36331811 | Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma |
| Q92580181 | Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements |
| Q36790362 | Annexin A2 heterotetramer: structure and function |
| Q48320617 | Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma |
| Q36294822 | Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. |
| Q37586765 | Annexin A2: its molecular regulation and cellular expression in cancer development |
| Q39158181 | Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance |
| Q37287432 | Annexin II represents metastatic potential in clear-cell renal cell carcinoma |
| Q33348548 | Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis |
| Q51748548 | B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? |
| Q33349898 | Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells |
| Q57135138 | Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity |
| Q39004813 | Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model |
| Q36614738 | Characterisation and protein expression profiling of annexins in colorectal cancer |
| Q38769873 | Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. |
| Q35900882 | Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2. |
| Q33908660 | Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas |
| Q100512247 | Concepts of extracellular matrix remodelling in tumour progression and metastasis |
| Q35343764 | Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer |
| Q92463707 | Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism |
| Q89454407 | Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors |
| Q39521584 | Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549. |
| Q53794062 | Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. |
| Q49859674 | Experimental models of pancreatic cancer desmoplasia. |
| Q55509468 | Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer. |
| Q50021996 | Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. |
| Q39671192 | Gemcitabine Resistance Induced by Interaction between Alternatively Spliced Segment of Tenascin-C and Annexin A2 in Pancreatic Cancer Cells |
| Q37321835 | Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention |
| Q35072508 | Gene expression profile during chondrogenesis in human bone marrow derived mesenchymal stem cells using a cDNA microarray |
| Q30754497 | Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression |
| Q37369869 | Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis |
| Q53531433 | In-depth quantitative proteomics for pancreatic cancer biomarker discovery. |
| Q41042149 | Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting |
| Q35689577 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells |
| Q26766065 | Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells |
| Q38630751 | Local and Systemic Expression of Immunomodulatory Factors in Chronic Pancreatitis |
| Q36898702 | Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells? |
| Q41338476 | Metastasis of pancreatic tumors |
| Q33508227 | Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients |
| Q38944901 | Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage. |
| Q36014277 | Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer |
| Q91870150 | Pathology of pancreatic cancer |
| Q36131172 | Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells |
| Q36073404 | Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer |
| Q42055572 | Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1α |
| Q80305915 | Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins |
| Q34783098 | Proteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis |
| Q39250856 | Proteomics-based analysis of invasion-related proteins in malignant gliomas |
| Q38845352 | RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway. |
| Q39939362 | RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer |
| Q37618014 | ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth |
| Q35928337 | Role of Annexin-II in GI cancers: interaction with gastrins/progastrins |
| Q36280897 | Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis |
| Q24311937 | S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility |
| Q33308802 | Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials |
| Q35071264 | Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma |
| Q24321623 | Splicing factor SRSF6 promotes hyperplasia of sensitized skin |
| Q52725586 | Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway. |
| Q90230532 | Structural and functional characterization of β2 -glycoprotein I domain 1 in anti-melanoma cell migration |
| Q36150219 | Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment |
| Q93208322 | Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma |
| Q90290815 | Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer |
| Q33957943 | Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway |
| Q44283570 | Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer |
| Q38908664 | Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway |
| Q27023815 | Tenascin-C: Form versus function |
| Q35952353 | The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog Pathway |
| Q36395285 | The annexin A2/S100A10 system in health and disease: emerging paradigms |
| Q84704993 | The association of annexin A2 and cancers |
| Q38366258 | The role of annexin A2 in tumorigenesis and cancer progression |
| Q84523428 | The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas |
| Q38099731 | Three are better than one: plasminogen receptors as cancer theranostic targets. |
| Q40141648 | Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. |
| Q58699630 | Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations |
| Q28740545 | Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer |
Search more.